Lumos Pharma (LUMO) Stock Highlights

4.34 | +0%

2024-12-21 07:22:31

Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates primarily in the United States.

Statistics

Range Today

4.34 4.34

Volume Today 0

Range 1 Year

1.37 4.58

Volume 1 Year 13.95M

Range 3 Year

1.37 10.27

Volume 3 Year 31.38M

Range 10 Year

0.82 58.73

Volume 10 Year 969.48M

Highlights

Market Capitalization 37.7M (micro)

Floating Shares 5.66M

Current Price 4.34

Price To Earnings -0.97

Price To Revenue 11.87

Price To Book 7.67

Earnings Per Share -4.46

Payout Ratio 0%

Performance

Latest 0%

1 Month +0.7%

3 Months +13.91%

6 Months +76.42%

1 Year +53.36%

3 Years -44.5%

5 Years +161.45%

10 Years -87.8%

Benchmarks

Market Capitalization

322 / 368

Gross Profits

121 / 278

Total Revenue

226 / 300

Total Rank

185 / 368

Free Cashflow

129 / 352

Performance 5 years

45 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.